HZN-825
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HZN-825, covering 2025-12-03 to 2026-03-20. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis [Phase 2]